BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37861978)

  • 1. Dual-energy CT improves differentiation of non-hypervascular pancreatic neuroendocrine neoplasms from CA 19-9-negative pancreatic ductal adenocarcinomas.
    Hu X; Shi S; Wang Y; Yuan J; Chen M; Wei L; Deng W; Feng ST; Peng Z; Luo Y
    Radiol Med; 2024 Jan; 129(1):1-13. PubMed ID: 37861978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential Diagnosis of Nonhypervascular Pancreatic Neuroendocrine Neoplasms From Pancreatic Ductal Adenocarcinomas, Based on Computed Tomography Radiological Features and Texture Analysis.
    Yu H; Huang Z; Li M; Wei Y; Zhang L; Yang C; Zhang Y; Song B
    Acad Radiol; 2020 Mar; 27(3):332-341. PubMed ID: 31495760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation of atypical pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinomas: Using whole-tumor CT texture analysis as quantitative biomarkers.
    Li J; Lu J; Liang P; Li A; Hu Y; Shen Y; Hu D; Li Z
    Cancer Med; 2018 Oct; 7(10):4924-4931. PubMed ID: 30151864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of Dual-Energy Computed Tomography for Detecting Small Pancreatic Ductal Adenocarcinoma.
    Fujisaki Y; Fukukura Y; Kumagae Y; Ejima F; Yamagishi R; Nakamura S; Kamizono J; Kurahara H; Hashimoto S; Yoshiura T
    Pancreas; 2022 Nov-Dec 01; 51(10):1352-1358. PubMed ID: 37099778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonhypervascular pancreatic neuroendocrine tumors: Spectrum of MDCT imaging findings and differentiation from pancreatic ductal adenocarcinoma.
    Karmazanovsky G; Belousova E; Schima W; Glotov A; Kalinin D; Kriger A
    Eur J Radiol; 2019 Jan; 110():66-73. PubMed ID: 30599875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative analysis of enhanced CT in differentiating well-differentiated pancreatic neuroendocrine tumors and poorly differentiated neuroendocrine carcinomas.
    Chen HY; Pan Y; Chen JY; Liu LL; Yang YB; Li K; Yu RS; Shao GL
    Eur Radiol; 2022 Dec; 32(12):8317-8325. PubMed ID: 35759016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low keV portal venous phase as a surrogate for pancreatic phase in a pancreatic protocol dual-energy CT: feasibility, image quality, and lesion conspicuity.
    Noda Y; Tochigi T; Parakh A; Joseph E; Hahn PF; Kambadakone A
    Eur Radiol; 2021 Sep; 31(9):6898-6908. PubMed ID: 33744992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of Quantitative Metrics From Dual-Layer Spectral-Detector CT for Differentiation of Pancreatic Neuroendocrine Tumor and Neuroendocrine Carcinoma.
    Wang Y; Hu X; Shi S; Song C; Wang L; Yuan J; Lin Z; Cai H; Feng ST; Luo Y
    AJR Am J Roentgenol; 2022 Jun; 218(6):999-1009. PubMed ID: 35043668
    [No Abstract]   [Full Text] [Related]  

  • 9. Nonhypervascular Pancreatic Neuroendocrine Tumors: Differential Diagnosis from Pancreatic Ductal Adenocarcinomas at MR Imaging-Retrospective Cross-sectional Study.
    Jeon SK; Lee JM; Joo I; Lee ES; Park HJ; Jang JY; Ryu JK; Lee KB; Han JK
    Radiology; 2017 Jul; 284(1):77-87. PubMed ID: 28092495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular volume fraction determined by equilibrium contrast-enhanced dual-energy CT as a prognostic factor in patients with stage IV pancreatic ductal adenocarcinoma.
    Fukukura Y; Kumagae Y; Higashi R; Hakamada H; Nakajo M; Maemura K; Arima S; Yoshiura T
    Eur Radiol; 2020 Mar; 30(3):1679-1689. PubMed ID: 31728691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation between non-hypervascular pancreatic neuroendocrine tumors and mass-forming pancreatitis using contrast-enhanced computed tomography.
    Wang Y; Chen X; Wang J; Cui W; Wang C; Chen X; Wang Z
    Acta Radiol; 2021 Feb; 62(2):190-197. PubMed ID: 32375515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual-energy computed tomography in a multiparametric regression model for diagnosing lymph node metastases in pancreatic ductal adenocarcinoma.
    Li S; Jiang D; Jiang L; Yan S; Liu L; Ruan G; Zhou X; Zhuo S
    Cancer Imaging; 2024 Mar; 24(1):38. PubMed ID: 38504330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between neuroendocrine carcinomas and well-differentiated neuroendocrine tumors of the pancreas using dynamic enhanced CT.
    Park HJ; Kim HJ; Kim KW; Kim SY; Choi SH; You MW; Hwang HS; Hong SM
    Eur Radiol; 2020 Sep; 30(9):4772-4782. PubMed ID: 32346794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreatic Neuroendocrine Neoplasms: CT Spectral Imaging in Grading.
    Li WX; Miao F; Xu XQ; Zhang J; Wu ZY; Chen KM; Yan FH; Lin XZ
    Acad Radiol; 2021 Feb; 28(2):208-216. PubMed ID: 32111466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation of duodenal gastrointestinal stromal tumors from hypervascular pancreatic neuroendocrine tumors in the pancreatic head using contrast-enhanced computed tomography.
    Ren S; Chen X; Wang J; Zhao R; Song L; Li H; Wang Z
    Abdom Radiol (NY); 2019 Mar; 44(3):867-876. PubMed ID: 30293109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of quantitative dual-energy computed tomography iodine maps and abdominal computed tomography perfusion measurements: are single-acquisition dual-energy computed tomography iodine maps more than a reduced-dose surrogate of conventional computed tomography perfusion?
    Stiller W; Skornitzke S; Fritz F; Klauss M; Hansen J; Pahn G; Grenacher L; Kauczor HU
    Invest Radiol; 2015 Oct; 50(10):703-8. PubMed ID: 26039774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simulated twin-phase pancreatic CT generated using single portal venous phase dual-energy CT acquisition in pancreatic ductal adenocarcinoma.
    Noda Y; Tochigi T; Parakh A; Kambadakone A
    Abdom Radiol (NY); 2021 Jun; 46(6):2610-2619. PubMed ID: 33454806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iodine quantification to distinguish hepatic neuroendocrine tumor metastasis from hepatocellular carcinoma at dual-source dual-energy liver CT.
    Kaltenbach B; Wichmann JL; Pfeifer S; Albrecht MH; Booz C; Lenga L; Hammerstingl R; D'Angelo T; Vogl TJ; Martin SS
    Eur J Radiol; 2018 Aug; 105():20-24. PubMed ID: 30017280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Grade 3 Pancreatic Neuroendocrine Tumors on MDCT: Establishing a Diagnostic Model and Comparing Survival Against Pancreatic Ductal Adenocarcinoma.
    Chen HY; Zhang XY; Deng XY; Ge YL; Tang YQ; Cui H; Yang B; Pan Y; Shi D; Yu RS
    AJR Am J Roentgenol; 2020 Aug; 215(2):390-397. PubMed ID: 32432906
    [No Abstract]   [Full Text] [Related]  

  • 20. Iodine concentration and tissue attenuation in dual-energy contrast-enhanced CT as a potential quantitative parameter in early detection of local pancreatic carcinoma recurrence after surgical resection.
    Mathy RM; Fritz F; Mayer P; Klauss M; Grenacher L; Stiller W; Kauczor HU; Skornitzke S
    Eur J Radiol; 2021 Oct; 143():109944. PubMed ID: 34482176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.